New product or service

Novo Nordisk Appeals TLV’s Denial of Wegovy Subsidy Over Prescription Concerns

Novo Nordisk challenges TLV’s subsidy denial for Wegovy, emphasizing cost-effectiveness and prescription controls amid obesity concerns.